Document is current
Any future updates will be listed below
-
Authors
Buchanan, Vanessa
Sullivan, Will
Graham, Chris
Miles, LaStella
Jugl, Steffen Marc
Gunda, Praveen
Halliday, Anna
Kirkham, Bruce
-
Funding
Funding for this research was provided by:
Novartis Pharmaceuticals UK Limited
- License Information
-
More Information
Article History
First Online: 25 May 2018
Compliance with Ethical Standards
:
: VB, WS, CG and LM declare they have no conflicts of interest. VB was (at the time of the study) and WS is an employee of BresMed Health Solutions, and CG and LM are employees of RTI Health Solutions; these organisations were contracted by Novartis Pharmaceuticals UK Ltd to undertake part of the work. SMJ is an employee of Novartis Pharma AG, Basel, Switzerland, and owns stock and stock options in Novartis Pharma AG, Basel, Switzerland. PG is an employee of Novartis Healthcare Private Limited, Hyderabad, India. AH is an employee of Novartis Pharmaceuticals UK Limited, Camberley, UK. BK has received research support from Abbvie, Eli Lilly & Co, Novartis, Roche, and UCB; honoraria from Eli Lilly & Co, Novartis, and Sandoz; and speaker fees from BMS, Janssen, Novartis, and Pfizer.
: This study was funded by Novartis Pharmaceuticals UK Ltd, Camberley, UK.
